# Neusignal Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neusignal-therapeutics

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.neusignal-tx.com
- Total disclosed funding: $12M
- Latest round: Series A (Jan 31, 2025)
- Investors on record: 7

## About

Based in Tokyo, Japan, and founded in 2022, Neusignal Therapeutics Inc. engages in the research and development of drugs to treat dementia and mental disorders. In March 2024, the firm raised JPY 1.33 billion in seed funding led by investors Fast Track Initiative, Keio Innovation Initiative, Mizuho Capital, Mitsubishi UFJ Capital, and SMBC Venture Capital. The firm as of March 2024, is led by its representative director, Yoshida Yoshifumi.

The company is dedicated to advancing the treatment of central nervous system diseases, particularly Alzheimer's disease (AD), through the development of small-molecule drugs. Neusignal Therapeutics also addresses the challenges posed by an aging population and the burden of nursing care, and protects brain health, through small-molecule oral drugs that enable fundamental treatment at home. The firm benefits from a strong collaboration system with Tohoku University and extensive networks with pharmaceutical companies and key opinion leaders in the AD field.

The company plans to utilize the March 2024 funding will be used to accelerate the clinical development of Alzheimer's disease treatment drugs.

## Funding rounds

- Series A, Jan 31, 2025, $7.4M — Nippon Venture Capital, Mitsubishi UFJ Capital, SMBC Venture Capital, Mizuho Capital, Fast Track Initiative, Keio Innovation Initiative, FFG Venture Business Partners
- Seed, Mar 1, 2024, $4.9M — Mitsubishi UFJ Capital, SMBC Venture Capital, Mizuho Capital, Fast Track Initiative, Keio Innovation Initiative

## Investors

- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Seed, Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Seed, Series A
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Seed, Series A
- Fast Track Initiative (https://capitalatlas.ai/funds/fast-track-initiative) — Seed, Series A
- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Seed, Series A
- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series A
- FFG Venture Business Partners (https://capitalatlas.ai/funds/ffg-venture-business-partners) — Series A